These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15919549)

  • 1. Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores.
    Calhoun-Haney R; Murphy C
    Brain Cogn; 2005 Jul; 58(2):178-82. PubMed ID: 15919549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of
    GoodSmith MS; Wroblewski KE; Schumm LP; McClintock MK; Pinto JM
    Neurology; 2023 Sep; 101(13):e1341-e1350. PubMed ID: 37495381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E status is associated with odor identification deficits in nondemented older persons.
    Murphy C; Bacon AW; Bondi MW; Salmon DP
    Ann N Y Acad Sci; 1998 Nov; 855():744-50. PubMed ID: 9929680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the ApoE epsilon4 allele on olfactory function in Down syndrome.
    Sliger M; Lander T; Murphy C
    J Alzheimers Dis; 2004 Aug; 6(4):397-402; discussion 443-9. PubMed ID: 15345810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4.
    Olofsson JK; Rönnlund M; Nordin S; Nyberg L; Nilsson LG; Larsson M
    Behav Genet; 2009 Sep; 39(5):496-503. PubMed ID: 19633944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory Dysfunction in ApoE ɛ4/4 Homozygotes with Alzheimer's Disease.
    Oleson S; Murphy C
    J Alzheimers Dis; 2015; 46(3):791-803. PubMed ID: 25869786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory function in people with genetic risk of dementia.
    Salerno-Kennedy R; Cusack S; Cashman KD
    Ir J Med Sci; 2005; 174(4):46-50. PubMed ID: 16445161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals.
    Olofsson JK; Larsson M; Roa C; Wilson DA; Jonsson Laukka E
    Behav Genet; 2020 Jan; 50(1):3-13. PubMed ID: 31760549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study.
    Riley KP; Snowdon DA; Saunders AM; Roses AD; Mortimer JA; Nanayakkara N
    J Gerontol B Psychol Sci Soc Sci; 2000 Mar; 55(2):S69-75. PubMed ID: 10794191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
    Reijs BLR; Ramakers IHGB; Elias-Sonnenschein L; Teunissen CE; Koel-Simmelink M; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Johannsen P; Vanderstichele H; Verhey F; Devanand DP; Visser PJ
    J Alzheimers Dis; 2017; 60(3):1025-1034. PubMed ID: 28984603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of the apolipoprotein E ε4 allele and olfactory function on odor identification networks.
    Frank C; Albertazzi A; Murphy C
    Brain Behav; 2024 May; 14(5):e3524. PubMed ID: 38702902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.
    Hirono N; Hashimoto M; Yasuda M; Kazui H; Mori E
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):354-8. PubMed ID: 12928512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The apolipoprotein E epsilon4 allele and incident Alzheimer's disease in persons with mild cognitive impairment.
    Aggarwal NT; Wilson RS; Beck TL; Bienias JL; Berry-Kravis E; Bennett DA
    Neurocase; 2005 Feb; 11(1):3-7. PubMed ID: 15804918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
    Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
    Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.